The Wuhan bio lab that was at the centre of controversy surrounding 'gain of function' research on coronaviruses appears to have been carrying out the same kind of research on monkeypox according to a report citing the peer reviewed journal Virologica Sinica which published the lab’s findings in February.
The National Pulse reports:
The Wuhan Institute of Virology assembled a monkeypox virus genome, allowing the virus to be identified through PCR tests, using a method researchers flagged for potentially creating a “contagious pathogen.”
Researchers appeared to identify a portion of the monkeypox virus genome, enabling PCR tests to identify the virus, in the paper: “Efficient Assembly of a Large Fragment of Monkeypox Virus Genome as a qPCR Template Using Dual-Selection Based Transformation-Associated Recombination“.
The paper acknowledged that this Transformation-Associated Recombination (TAR) “applied in virological research could also raise potential security concerns, especially when the assembled product contains a full set of genetic material that can be recovered into a contagious pathogen.”
The revelations follow on from suggestions from a source within the European Centers For Disease Control that the current strain of monkeypox rapidly spreading across the globe appears to be “a third lab strain with unknown characteristics, and that there is chatter about this being somehow related to Moscow’s charges against U.S. biological activities in Ukraine.” This information, along with several other reports indicating that drills and ‘war game’ scenarios by the WHO and the Gates Foundation involving monkeypox will once again serve to stoke fears that the outbreak could have originated from a bio lab. The full report can be downloaded here: https://www.scribd.com/document/575186014/1-s2-0-S1995820X22000414-main#download&from_embed